Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 62 locations
View Trial Details
Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07227012

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +13 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 49 locations
View Trial Details
Recruiting

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

NCT07219459

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Peidmont Healthcare, Inc Atlanta, Georgia, United States
  • OSF St. Francis Medical Center Peoria, Illinois, United States
  • Hannover Medical School Hanover, Lower Saxony, Germany
View all 14 locations
View Trial Details
Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Monash Medical Centre Clayton, Victoria, Australia
View all 31 locations
View Trial Details
Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

NCT07419841

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • START New York Lake Success, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 91 locations
View Trial Details

Related conditions